下一代测序在儿科神经疾病中的实用性:来自南非的经验

Magriet van Niekerk1, Shahida Moosa2,3, Ronald van Toorn1

  • 1Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

概括

下一代测序 (NGS) 为南非的儿童神经疾病提供了高诊断收益率 (45%),类似于高收入国家. 针对性基因小组对于神经肌肉疾病和性脑病变等特定疾病具有成本效益.